The FDA's decision to fully license the Pfizer-BioNTech COVID-19 vaccine is expected to trigger more mandates and allow marketing of the shot.
Pfizer-BioNTech COVID-19 vaccine becomes first to win FDA’s full approval, paving way for boosters, mandates
